BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7011010)

  • 1. Extralymphatic Hodgkin's disease. Prognosis and response to therapy.
    Torti FM; Portlock CS; Rosenberg SA; Kaplan HS
    Am J Med; 1981 Mar; 70(3):487-92. PubMed ID: 7011010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
    Levi JA; Wiernik PH
    Cancer; 1977 May; 39(5):2158-65. PubMed ID: 404027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later.
    Wiernik PH; Gustafson J; Schimpff SC; Diggs C
    Am J Med; 1979 Aug; 67(2):183-98. PubMed ID: 380335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefit.
    Gomez GA; Reese PA; Nava H; Panahon AM; Barcos M; Stutzman L; Han T; Henderson ES
    Am J Med; 1984 Aug; 77(2):205-10. PubMed ID: 6380286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Hodgkin's disease in children and adolescents.
    Lange B; Littman P
    Cancer; 1983 Apr; 51(8):1371-7. PubMed ID: 6402288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
    Crnkovich MJ; Leopold K; Hoppe RT; Mauch PM
    J Clin Oncol; 1987 Jul; 5(7):1041-9. PubMed ID: 3598608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment.
    Mintz U; Miller JB; Golomb HM; Kinzie J; Sweet DL; Lester EP; Variakojis D; Roth NO; Blough RR; Ferguson DJ; Ultmann JE
    Cancer; 1979 Jul; 44(1):72-9. PubMed ID: 110438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
    Crowther D; Wagstaff J; Deakin D; Todd I; Wilkinson P; Anderson H; Blackledge G; Jones M; Scarffe JH
    J Clin Oncol; 1984 Aug; 2(8):892-7. PubMed ID: 6379122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extralymphatic involvement in diffuse non-Hodgkin's lymphoma.
    Paryani S; Hoppe RT; Burke JS; Sneed P; Dawley D; Cox RS; Rosenberg SA; Kaplan HS
    J Clin Oncol; 1983 Nov; 1(11):682-8. PubMed ID: 6422003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease in patients over sixty years old.
    Austin-Seymour MM; Hoppe RT; Cox RS; Rosenberg SA; Kaplan HS
    Ann Intern Med; 1984 Jan; 100(1):13-8. PubMed ID: 6691638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
    Leslie NT; Mauch PM; Hellman S
    Cancer; 1985 May; 55(9 Suppl):2072-8. PubMed ID: 3919921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
    Goodman R; Mauch P; Piro A; Rosenthal D; Goldstein M; Tullis J; Hellman S
    Cancer; 1977 Jul; 40(1):84-9. PubMed ID: 406981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage IIB Hodgkin's disease: the Stanford experience.
    Crnkovich MJ; Hoppe RT; Rosenberg SA
    J Clin Oncol; 1986 Apr; 4(4):472-9. PubMed ID: 3958761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
    Engert A; Plütschow A; Eich HT; Lohri A; Dörken B; Borchmann P; Berger B; Greil R; Willborn KC; Wilhelm M; Debus J; Eble MJ; Sökler M; Ho A; Rank A; Ganser A; Trümper L; Bokemeyer C; Kirchner H; Schubert J; Král Z; Fuchs M; Müller-Hermelink HK; Müller RP; Diehl V
    N Engl J Med; 2010 Aug; 363(7):640-52. PubMed ID: 20818855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy in the management of bulky mediastinal Hodgkin's disease.
    Behar RA; Hoppe RT
    Cancer; 1990 Jul; 66(1):75-9. PubMed ID: 2354412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in pathological stage IIIA Hodgkin's disease.
    Hoppe RT; Rosenberg SA; Kaplan HS; Cox RS
    Cancer; 1980 Sep; 46(5):1240-6. PubMed ID: 7214305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.